These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 16820147)
1. Functional expression of the P2Y14 receptor in human neutrophils. Scrivens M; Dickenson JM Eur J Pharmacol; 2006 Aug; 543(1-3):166-73. PubMed ID: 16820147 [TBL] [Abstract][Full Text] [Related]
2. Functional expression of the P2Y14 receptor in murine T-lymphocytes. Scrivens M; Dickenson JM Br J Pharmacol; 2005 Oct; 146(3):435-44. PubMed ID: 15997228 [TBL] [Abstract][Full Text] [Related]
3. Pharmacological effects mediated by UDP-glucose that are independent of P2Y14 receptor expression. Scrivens M; Dickenson JM Pharmacol Res; 2005 Jun; 51(6):533-8. PubMed ID: 15829433 [TBL] [Abstract][Full Text] [Related]
4. Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1). Fang Y; Olah ME J Pharmacol Exp Ther; 2007 Sep; 322(3):1189-200. PubMed ID: 17565009 [TBL] [Abstract][Full Text] [Related]
5. Gi-dependent cell signaling responses of the human P2Y14 receptor in model cell systems. Fricks IP; Carter RL; Lazarowski ER; Harden TK J Pharmacol Exp Ther; 2009 Jul; 330(1):162-8. PubMed ID: 19339661 [TBL] [Abstract][Full Text] [Related]
15. Regulation of human hepatocytes by P2Y receptors: control of glycogen phosphorylase, Ca2+, and mitogen-activated protein kinases. Dixon CJ; White PJ; Hall JF; Kingston S; Boarder MR J Pharmacol Exp Ther; 2005 Jun; 313(3):1305-13. PubMed ID: 15764738 [TBL] [Abstract][Full Text] [Related]
16. P2Y receptor activation enhances insulin release from pancreatic beta-cells by triggering the cyclic AMP/protein kinase A pathway. Chevassus H; Roig A; Belloc C; Lajoix AD; Broca C; Manteghetti M; Petit P Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):464-9. PubMed ID: 12382076 [TBL] [Abstract][Full Text] [Related]
17. DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shock-induced lung injury in rats. Yu HP; Hsieh PW; Chang YJ; Chung PJ; Kuo LM; Hwang TL Biochem Pharmacol; 2009 Oct; 78(8):983-92. PubMed ID: 19540209 [TBL] [Abstract][Full Text] [Related]
18. P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome. Schrader AM; Camden JM; Weisman GA Arch Oral Biol; 2005 Jun; 50(6):533-40. PubMed ID: 15848146 [TBL] [Abstract][Full Text] [Related]
19. Viscolin, a new chalcone from Viscum coloratum, inhibits human neutrophil superoxide anion and elastase release via a cAMP-dependent pathway. Hwang TL; Leu YL; Kao SH; Tang MC; Chang HL Free Radic Biol Med; 2006 Nov; 41(9):1433-41. PubMed ID: 17023270 [TBL] [Abstract][Full Text] [Related]
20. Extracellular ATP activates ERK1/ERK2 via a metabotropic P2Y1 receptor in a Ca2+ independent manner in differentiated human skeletal muscle cells. May C; Weigl L; Karel A; Hohenegger M Biochem Pharmacol; 2006 May; 71(10):1497-509. PubMed ID: 16533496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]